Clinical Trial Update: Efficacy And Safety Of Tofacitinib In Chinese Subjects With Active Psoriatic Arthritis [Phase 3]

View source ↗

Summary

Phase 3 trial update on tofacitinib in Chinese patients with active psoriatic arthritis reports efficacy and safety results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Psoriatic Arthritis

Drugs mentioned

• Tofacitinib (tofacitinib)

Snippet

Sponsor: Pfizer | Conditions: Psoriatic Arthritis | Phase 3 | Status: COMPLETED | Results posted: 2024-02-08